Evidence map›Paper›PMID 37254450›Full record

ArticleAging2023

Correction for: Long intergenic non-protein coding RNA 324 prevents breast cancer progression by modulating miR-10b-5p.

Bo Wang, Yangyang Zhang, Haitian Zhang, Faquan Lin, Qixin Tan, Qinghong Qin, Wei Bao, Yi Liu, Jiaying Xie, Qiyan Zeng

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Bo WangDepartment of Biochemistry and Molecular Biology, Guangxi Medical University, Nanning 530021, Guangxi, P.R. China.
Yangyang ZhangDepartment of Biochemistry and Molecular Biology, Guangxi Medical University, Nanning 530021, Guangxi, P.R. China.
Haitian ZhangDepartment of Gastrointestinal and Gland Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, P.R.China.
Faquan LinKey Laboratory of Biological Molecular Medicine Research, Guangxi Medical University, Nanning 530021, Guangxi, P.R. China.
Qixin TanDepartment of Breast Surgery, Guangxi Medical University Tumor Hospital, Nanning 530021, Guangxi, P.R. China.
Qinghong QinDepartment of Breast Surgery, Guangxi Medical University Tumor Hospital, Nanning 530021, Guangxi, P.R. China.
Wei BaoDepartment of Biochemistry and Molecular Biology, Guangxi Medical University, Nanning 530021, Guangxi, P.R. China.
Yi LiuDepartment of Biochemistry and Molecular Biology, Guangxi Medical University, Nanning 530021, Guangxi, P.R. China.
Jiaying XieDepartment of Biochemistry and Molecular Biology, Guangxi Medical University, Nanning 530021, Guangxi, P.R. China.
Qiyan ZengDepartment of Biochemistry and Molecular Biology, Guangxi Medical University, Nanning 530021, Guangxi, P.R. China.
Guangxi Medical University · CNTumor Hospital of Guangxi Medical University · CNFirst Affiliated Hospital of GuangXi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerceRNAE-cadherinLINC00324miR-10b-5p

Identifiers

PMID37254450
PMCPMC10258004
OpenAlexW4378783507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.